Vericel Corp.

Vericel Corp. (NASDAQ:VRCL) delivers cutting‑edge cellular therapies for knee cartilage repair (MACI) and burn care (Epicel, NexoBrid), positioning it as a market‑leader in regenerative medicine for orthopedics and burn treatment.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 357
HQ: Cambridge

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
VCEL	Vericel Corp. Cap: 2.0B \| P/E: 149.2	EQUITY	NCM	USD	US92346J1088	Active	📈